Product
Enoxacin
1 clinical trial
1 indication
Indication
Amyotrophic lateral sclerosisClinical trial
A Randomized, Double-blind, Parallel Group, Single Centre, Phase 1b/2 Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Three Orally Administered Doses of Enoxacin (200mg Twice Daily, 400mg Twice Daily and 600mg Twice Daily) in Adults With Amyotrophic Lateral SclerosisStatus: Completed, Estimated PCD: 2023-11-15